Re: Patent Expiration-enough
in response to
by
Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.
Message: Re: Patent Expiration-enough
| Application Number: | 08/484,918 | Correspondence Address Customer Number: | 40972 |
| Filing or 371 (c) Date: | 06-07-1995 | Status: | Patented Case |
| Application Type: | Utility | Status Date: | 07-15-1998 |
| Examiner Name: | ENG, DAVID Y | Location: 
|
ELECTRONIC |
| Group Art Unit: | 2784 | Location Date: | - |
| Confirmation Number: | 5043 | Earliest Publication No: | - |
| Attorney Docket Number: | 0081-011D3 | Earliest Publication Date: | - |
| Class / Subclass: | 395/845 | Patent Number: | 5,809,336 |
| First Named Inventor: | CHARLES H. MOORE , WOODSIDE, CA (US) all Inventors | Issue Date of Patent: | 09-15-1998 |
| First Named Applicant: | - | International Registration Number (Hague): | - |
| Entity Status: | Undiscounted | International Registration Publication Date: | - |
| AIA (First Inventor to File): | No |
http://portal.uspto.gov/pair/PublicPair
(patent 5809336)
Basd on the letter below, my guess is Sept. 15, 2015
See image file wrapper
| 09-15-1998 | CTMS | Miscellaneous Action with SSP |
http://portal.uspto.gov/pair/view/BrowsePdfServlet?objectId=FG4WXB0WPPOPPY5&lang=DINO
New Message
Please
login
to post a reply